Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.
about
Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Clinical implications of pharm ...... renal cell carcinoma patients.
@en
Clinical implications of pharm ...... renal cell carcinoma patients.
@nl
type
label
Clinical implications of pharm ...... renal cell carcinoma patients.
@en
Clinical implications of pharm ...... renal cell carcinoma patients.
@nl
prefLabel
Clinical implications of pharm ...... renal cell carcinoma patients.
@en
Clinical implications of pharm ...... renal cell carcinoma patients.
@nl
P2093
P2860
P356
P1433
P1476
Clinical implications of pharm ...... renal cell carcinoma patients.
@en
P2093
Atsushi Maeno
Hiroshi Tsuruta
Kazuyuki Numakura
Makoto Takahashi
Masatomo Miura
Mingguo Huang
Mitsuru Saito
Nobuhiro Fujiyama
Norihiko Tsuchiya
Ryoma Igarashi
P2860
P304
25277-25284
P356
10.18632/ONCOTARGET.25423
P407
P577
2018-05-18T00:00:00Z